Comprehensive Review of Advances and Translational Obstacles in Intelligent Multimodal Monitoring for Parkinson's Disease - Top-Institutions - MDSpire

Comprehensive Review of Advances and Translational Obstacles in Intelligent Multimodal Monitoring for Parkinson's Disease

  • By

  • Jianhui Tan

  • Xiuzhen Deng

  • Cuilan Wu

  • Molin Yao

  • Jingyi Liao

  • Haoli Zheng

  • Changlin Lian

  • April 17, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Neurology
    • Movement Disorders
    • Biomedical Engineering

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Neurology
    • Movement Disorders
    • Clinical Research

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Neurology
    • Biomedical Engineering
    • Data Science

  • #4

    Massachusetts General Hospital (MGH) / Harvard Medical School
    Massachusetts General Hospital (MGH) / Harvard Medical School

    Boston, MA

    Key Differentiators

    • Neurology
    • Movement Disorders
    • Biomedical Informatics

  • #5

    University of Pennsylvania (Penn Medicine)
    University of Pennsylvania (Penn Medicine)

    Philadelphia, PA

    Key Differentiators

    • Neurology
    • Biomedical Engineering
    • Clinical Neuroscience

Original Source(s)

Comprehensive Review of Advances and Translational Obstacles in Intelligent Multimodal Monitoring for Parkinson's Disease

  • by Jianhui Tan, Xiuzhen Deng, Cuilan Wu, Molin Yao, Jingyi Liao, Haoli Zheng, Changlin Lian

  • April 17, 2026

Related Content

Exposure to Air Pollutants and Lewy Body and Parkinson Disease–Related Dementias

Evaluating impulse control disorders in people with Parkinson’s disease: agreement and added value of patient and caregiver reports

A Clinically Relevant and Understandable Approach to Developing Digital Speech Biomarkers for Neurodegenerative Disorders